User:Etchevers/Notebook/Conference notes/2010/06/27: Difference between revisions
(Autocreate 2010/06/27 Entry for User:Etchevers/Notebook/Conference_notes) |
|||
| Line 7: | Line 7: | ||
<!-- ##### DO NOT edit above this line unless you know what you are doing. ##### --> | <!-- ##### DO NOT edit above this line unless you know what you are doing. ##### --> | ||
==Notes for ( | ==Notes for seminar by Frederic Causeret ([http://www.ijm.fr/fr/ijm/recherche/equipes/cortex-cerebral/ A. Pierani group]), May 2010== | ||
Brainbow mice – heterogeneity in a homogeneous population cf Jean Livet. Tool. | |||
Developing brain homeobox = Dbx. Alessandra worked on this with Tom Jessell – specifies Vo interneurons. | |||
Cajal-Retzius cells produce reelin – direct radial migration in cortex. | |||
Label with a Dbx promoter in front of lacZ, or the whole gene – IRES – GFP or the whole gene – IRES – Cre and then cross with a Rosa26 – loxP – STOP – loxP – YFP mouse. | |||
Traces indelible over time. | |||
To get cell ablation cross the Dbx1 promoter-driven IRES loxP – STOP – loxP – diphtheria toxin construct mouse, with a generic promoter Cre recombinase mouse. The toxin can not get into neighboring cells. Can also use Emx1-driven or p73-driven Cre. | |||
Affects frontomedial motor cortex by changing the expression of Pax6 / Emx2 / Sp8 domains. | |||
Tbr2+ (Eomes!) progenitors are intermediate and within the SVZ, not the ventricle. Reduction in proliferative divisions and increase of Tbr2+ neurogenic divisions and differentiation, in a Dbx1 -/- background. | |||
The Rosa-YFP labeled cells – sort selectively then microarrays to show which signaling factors are made by Cajal-Retzius cells eg FGF15/17. | |||
Pool of CR cells from the boundary between pallium/subpallium also gives rise to later generated E12-E16 cortical plate, glutaminergic cells, that are transitory. | |||
Then described use of Ngn2-driven Cre (Why?) mice to remove these Dbx1+ cells – this leads to reduction of the upper layers of progenitors through depletion. (Aren't these the Tbr2+ cells?) | |||
When use Pgk-Cre (ubiquitous promoter) cross get truncation of head, just leaving the ears. Like reverse otocephaly. (Re: Otx2? I think I even asked this question and don't remember the answer. How embarrassing.) | |||
Only a ventral bit of the Emx1/Foxg1 domains remaining. Normal eyes but synophthalmic (– implying some effect either on or downstream of Shh pathway / MID1.) Cf: Nestin-Cre; Dbx1 (DTA) – much less severe effect because happens after E10.5 | |||
The mutants have a phenotype though already at E9.5 (which mutants?) | |||
NT closure at 8-12 ss, E8.5-8.75 | |||
NT closed at 15 ss, E9 | |||
Start seeing problems at E8.5, early dynamic expression that can change and come on/off within a few hours. | |||
at 20ss, ventral medial telencephalon floorplate cells. | |||
Dorsal expression of Dbx1::Cre;Rosa26-YFP leads to some Sox10++ cells (not a lot, but they're there in the mesenchyme). Specification appears normal as well as a proliferation marker, PH3. | |||
But lots of dorsal apoptosis. | |||
(The idea is that by getting rid of this special neural crest-like population derived from Dbx1+ cells, the way I had done years ago by physical ablations of the neural folds, this is instrumental in causing the phenotype.) | |||
Then did targeted ablations – Wnt1-Cre, Nkx2.1-Cre or FoxG1-Cre. For Nkx2.1-Cre, loss of ventral Shh but also displacement of other signaling centers like Fgf8. Each had a bit of an effect, implying cooperation of different subsets of cell populations. So did the triple Cre vs the Pgk-Cre phenotype; in the former, there is a telencephalon. | |||
(I wrote something about the diencephalon-mesencephalon boundary for some reason.) | |||
Expression analyses – all Shh, Fgfs 7/8/15/17/18 but Wnt1/7a in Dbx1+ cells, however, BMP2/7/Noggin not by Dbx1+ cells themselves, rather in their neighbors, and their levels are affected. | |||
Dependence receptors – withdrawal leads to apoptosis: Ret, DCC, p75, alpha-v-beta-3 integrin, Patched, Unc5h2. | |||
Neogenin is in the neural plate: RGMb in Dbx1+ cells as well as others. | |||
Millicell explants of neural plates in a pretty in vitro assay – try soluble candidates to get Dbx1 cells to survive. | |||
Revision as of 14:37, 27 June 2010
 Conference and seminar notes
|
<html><img src="/images/9/94/Report.png" border="0" /></html> Main project page <html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html> </html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html> |
Notes for seminar by Frederic Causeret (A. Pierani group), May 2010Brainbow mice – heterogeneity in a homogeneous population cf Jean Livet. Tool. Developing brain homeobox = Dbx. Alessandra worked on this with Tom Jessell – specifies Vo interneurons. Cajal-Retzius cells produce reelin – direct radial migration in cortex. Label with a Dbx promoter in front of lacZ, or the whole gene – IRES – GFP or the whole gene – IRES – Cre and then cross with a Rosa26 – loxP – STOP – loxP – YFP mouse. Traces indelible over time. To get cell ablation cross the Dbx1 promoter-driven IRES loxP – STOP – loxP – diphtheria toxin construct mouse, with a generic promoter Cre recombinase mouse. The toxin can not get into neighboring cells. Can also use Emx1-driven or p73-driven Cre. Affects frontomedial motor cortex by changing the expression of Pax6 / Emx2 / Sp8 domains. Tbr2+ (Eomes!) progenitors are intermediate and within the SVZ, not the ventricle. Reduction in proliferative divisions and increase of Tbr2+ neurogenic divisions and differentiation, in a Dbx1 -/- background. The Rosa-YFP labeled cells – sort selectively then microarrays to show which signaling factors are made by Cajal-Retzius cells eg FGF15/17. Pool of CR cells from the boundary between pallium/subpallium also gives rise to later generated E12-E16 cortical plate, glutaminergic cells, that are transitory. Then described use of Ngn2-driven Cre (Why?) mice to remove these Dbx1+ cells – this leads to reduction of the upper layers of progenitors through depletion. (Aren't these the Tbr2+ cells?) When use Pgk-Cre (ubiquitous promoter) cross get truncation of head, just leaving the ears. Like reverse otocephaly. (Re: Otx2? I think I even asked this question and don't remember the answer. How embarrassing.) Only a ventral bit of the Emx1/Foxg1 domains remaining. Normal eyes but synophthalmic (– implying some effect either on or downstream of Shh pathway / MID1.) Cf: Nestin-Cre; Dbx1 (DTA) – much less severe effect because happens after E10.5 The mutants have a phenotype though already at E9.5 (which mutants?) NT closure at 8-12 ss, E8.5-8.75 NT closed at 15 ss, E9 Start seeing problems at E8.5, early dynamic expression that can change and come on/off within a few hours. at 20ss, ventral medial telencephalon floorplate cells. Dorsal expression of Dbx1::Cre;Rosa26-YFP leads to some Sox10++ cells (not a lot, but they're there in the mesenchyme). Specification appears normal as well as a proliferation marker, PH3. But lots of dorsal apoptosis. (The idea is that by getting rid of this special neural crest-like population derived from Dbx1+ cells, the way I had done years ago by physical ablations of the neural folds, this is instrumental in causing the phenotype.) Then did targeted ablations – Wnt1-Cre, Nkx2.1-Cre or FoxG1-Cre. For Nkx2.1-Cre, loss of ventral Shh but also displacement of other signaling centers like Fgf8. Each had a bit of an effect, implying cooperation of different subsets of cell populations. So did the triple Cre vs the Pgk-Cre phenotype; in the former, there is a telencephalon. (I wrote something about the diencephalon-mesencephalon boundary for some reason.) Expression analyses – all Shh, Fgfs 7/8/15/17/18 but Wnt1/7a in Dbx1+ cells, however, BMP2/7/Noggin not by Dbx1+ cells themselves, rather in their neighbors, and their levels are affected. Dependence receptors – withdrawal leads to apoptosis: Ret, DCC, p75, alpha-v-beta-3 integrin, Patched, Unc5h2. Neogenin is in the neural plate: RGMb in Dbx1+ cells as well as others. Millicell explants of neural plates in a pretty in vitro assay – try soluble candidates to get Dbx1 cells to survive.
| |
